Showing 661-670 of 7444 results for "".
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-new-data-presented-for-atopic-dermatitis-and-prurigo-nodularis-candidates-at-aad/24127/In this episode of DermWireTV, a phase 3 study finds roflumilast cream is associated with significantly improved atopic dermatitis in children; first-of-its-kind research suggests that eczema treatment lebrikizumab shows efficacy and safety in patients with skin of color; and new data reveals oral JLooking to the Sea: Kelp-Based Formula Shows Anti-Aging Effects and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/looking-to-the-sea-kelp-based-formula-shows-anti-aging-effects-and-more/23979/A fermented kelp-based product showed anti-inflammatory and anti-aging results in some studies.Acne and Rosacea Awareness: Clinician Perspectives
https://practicaldermatology.com/topics/acne-rosacea/acne-and-rosacea-awareness-clinician-perspectives/23927/Key ways to improve treatment outcomes for patients with rosacea and acne.DermWire TV: Positive Data on UCB's Bimekizumab in HS patients; CSF takes Nashville by Storm; Rocatinlimab Performs Well in AD
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-positive-data-on-ucbs-bimekizumab-hs-patients-csf-takes-nashville-by-storm-rocatinlimab-performs-well-in-ad/20159/Bimekizumab performs well in Hidradenitis Suppurativa patients, Cosmetic Surgery Forum takes Nashville by storm, and Rocatinlimab—a novel monoclonal antibody therapy—shows promise in atopic dermatitis are the stories topping the news in this episode of DermWireTV.SEO Myths About Duplicate Content
https://practicaldermatology.com/topics/practice-management/seo-myths-about-duplicate-content/23726/Issues around duplicate content can be surprisingly complex.DermWireTV: Medicare Cuts; Revision, Alastin, Obagi Acquisitions; CSF Hits Nashville
https://practicaldermatology.com/topics/practice-management/dermwiretv-medicare-cuts-revision-alastin-obagi-acquisitions-csf-hits-nashville/20033/Congress is working to avert a potential pay cut for physicians who treat Medicare patients, and a bipartisan solution has been introduced. Cuts loom as the AMA has released data showing that Medicare claims data exclusive to physician services fell an estimated $13.9 billion or 14 percent below expExamining the Emotional Impact of Acne in a Virtual World
https://practicaldermatology.com/columns/clinical-focus-1/examining-the-emotional-impact-of-acne-in-a-virtual-world/23577/Acne patients are working hard to conceal their acne on Zoom.New Directions in Acne Care
https://practicaldermatology.com/topics/acne-rosacea/new-directions-in-acne-care/23515/Recent developments and therapeutic advancements continue to improve outcomes in the management of this common, inflammatory disease.A Mainstay in Treating Acne: The Role of Benzoyl Peroxide
https://practicaldermatology.com/topics/acne-rosacea/a-mainstay-in-treating-acne-the-role-of-benzoyl-peroxide/23307/Products like La Roche-Posay’s Effaclar Duo are effective in the management of acne.Protecting Your Most Valuable Asset: Insurance
https://practicaldermatology.com/topics/practice-management/protecting-your-most-valuable-asset-insurance/20817/A refresher on what you need to know about term life, permanent (cash value) life, and disability insurance.